MOBILE VIEW  | 

PLANTS-EUPHORBIACEAE

Classification   |    Detailed evidence-based information

Therapeutic Toxic Class

    A) The Euphorbiaceae, also called spurges, are found worldwide. They are used as foods, as medicines, and have industrial uses. As medicinal and toxic agents, they are best known for their purgative, tumor promoting and irritant principles.

Specific Substances

    A) CONSTITUENTS OF THE GROUP
    1) Cleistanthus collinus
    2) Daphnane Esters
    3) Diterpenoids
    4) Euphorbiaceae
    5) Euphorbia paralias
    6) Ingenane esters
    7) Ingenol Esters
    8) Ingenol 3-hexadecanoate
    9) Jolokinol A & B
    10) Phorbol Esters
    11) Tigliane Esters
    12) TPA: 12-O-tetradecanoylphorbol-13-acetate

Available Forms Sources

    A) FORMS
    1) Plants included in this management and their toxin (Gundidza et al, 1993; Gundidza et al, 1992; Furstenberger & Hecker, 1986; Adolf et al, 1984) (Frohne & Pfander, 1983)(Kinghorn, 1979; Upadhyay et al, 1976):
    Baliospermum montanumMontanin
    Cleistanthus collinusArylnaphthalene lignan lactones diphyllin & collinusin
    Croton sparsiflorusPhorbol diesters
    Croton tigliumPhorbol esters (14) including TPA
    Elaeophorbia drupiferaIngenol esters
    Elaeophorbia grandifloriaIngenol esters
    Euphorbia biglandulosaIngenol esters
    Euphorbia coerulescensPhorbol diesters
    Euphorbia cooperiPhorbol esters
    Euphorbia cyparissiasIngenol esters
    Euphorbia erythraeaIngenol esters
    Euphorbia esulaIngenol esters
    Euphorbia franckianaPhorbol diesters
    Euphorbia helioscopia12-Deoxyphorbol
    Euphorbia ingensIngenol 3 hexadecanoate
    Euphorbia kansuiIngenol esters
    Euphorbia lacteaIngenol esters
    Euphorbia lathyrisIngenol 3 hexadecanoate & jolkinols
    Euphorbia matabelensisIngenol ester
    Euphorbia miliiIngenol esters
    Euphorbia peplusIngenol, 5-Deoxyingenol
    Euphorbia poisoniiResiniferatoxin & Tinyatoxin
    Euphorbia pulcherrimaNone
    Euphorbia resiniferaRL-14 & Resiniferatoxin
    Euphorbia segueirianaIngenol esters
    Euphorbia serrataIngenol-3-palmitate
    Euphorbia strictaIngenol, 5-Deoxyingenol
    Euphorbia tirucalliPhorbol 12, 13-diesters & ingenol esters, euphorcinol
    Euphoria myrsinitesIngenol, 5-Deoxyingenol
    Hippomane mancinellaHuratoxin
    Hippomane mancinellaFactor M2
    Hura crepitansHuratoxin
    Mabea excelsea5-deoxy-13-hydroxy-ingenol
    Sapium japonicumPhorbol diesters

    B) USES
    1) MEDICAL
    a) Various Euphorbia species have been used for removal of warts, and as emetics and purgatives. In general, the irritant action is too drastic for the plants to be useful (Cooper & Johnson, 1984).
    b) Euphorbium is a natural drug used in irritant plasters and as a cathartic up through the early 1900's. It is composed of the air-dried latex of E. resinifera. It owes its irritant nature to diterpene esters (Hergenhahn et al, 1974). Euphorbium compositum(R) is a combination homeopathic preparation used in the treatment of colds and sinus infections. Limited antiviral activity was noted in plaque reduction assays of two of the components, Euphorbia resinifera and Pulsatilla pratensis (Glatthaar-Saalmuller & Fallier- Becker, 2001).
    c) The Euphorbiaceae, also called spurges, are found worldwide. They are used as foods, as medicines, and have industrial uses. As medicinal and toxic agents, they are best known for their purgative, tumor promoting, and irritant principles (Kinghorn, 1979).
    d) As irritant co-carcinogens, they are used to study skin carcinogenesis. They also have anti-leukemic effects (Kinghorn, 1979).
    e) EUPHORBIA PARALIAS: It is a hardy perennial that inhabits sandy coasts and beaches and is native to the entire Mediterranean region. It is also the most common Euphorbia species that grows in Egypt. This plant has been used in traditional medicine as a purgative and local anesthetic (Boubaker et al, 2013).
    f) EUPHORBIA PEPLUS: Has undergone both scientific and lay investigation for treatment of basal cell carcinoma. Although some success has been reported in initial studies, there have also been reports of the plant masking symptoms until the carcinoma is more fully developed (Flood & Beardmore, 1976).
    g) EUPHORBIA TIRUCALLI: Is widely distributed in both Asia and Africa, and is used by the natives internally as a general purgative, and treatment for colic, asthma, and gastralgia. Externally it has been used as treatment for rheumatism, neuralgia, and toothache (Khan et al, 1987) 1989).
    h) SYNDENDIUM GRANTII: This is a succulent shrub which may grow up to 10 feet tall. It is native to Africa, but is used as a house or greenhouse plant in other parts of the world, including the United States and Britain. In Africa, the latex is used as a poison (Raymond, 1939).

Life Support

    A) This overview assumes that basic life support measures have been instituted.

Clinical Effects

    0.2.1) SUMMARY OF EXPOSURE
    A) BACKGROUND: Euphorbiaceae, also known as spurges, are a family of plants found worldwide. They are used as foods, medicines, and industrial uses. As medicinal and toxic agents, they are best known for their purgative, tumor promoting and irritant properties.
    B) TOXICOLOGY: The toxicity of Euphorbiaceae depends on the specific plants of the family and the various parts of each plant. For instance, resiniferatoxin, which is an extremely potent capsaicin analog, can be found in Euphorbia resinifera and Euphorbia poissonii. Euphorbia marinata contains a ribosome inactivating protein in its latex. Tumor promotion substances include the ingenane and tigliane diterpene esters, which are also irritants.
    C) EPIDEMIOLOGY: Euphorbiaceae plants are found worldwide and thus exposures to people are extremely common. Though most plants in this family are found in tropical areas, there are species found in nontropical areas as well. Prominent plants that people may come in contact with includes cassava, castor oil plants, and poinsettias.
    D) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE EXPOSURES: Some plants in this family contain irritant diterpene esters that can be irritating. Ingestion may cause oral irritation, gastritis, vomiting and diarrhea. In addition, ingestion may cause a burning sensation of the mouth, throat, lips, and buccal surfaces. Erythema and swelling are also common. After ingesting a soup containing Breynia officinalis, hepatotoxicity was reported. The most commonly reported toxicity is dermal, due to the milky latex excreted by some of these plants that can cause contact erythema, swelling, and the formation of blisters and vesicles.
    2) SEVERE EXPOSURES: Systemic symptoms are rare but may include giddiness, electrolyte disturbances (hypokalemia), cardiac toxicity (ECG abnormalities), CNS toxicity (seizures, coma, neuromuscular weakness), renal and respiratory failure and even death. Specifically, cardiac dysrhythmias and hypotension have developed after ingestion of Cleistanthus collinus extract and leaves. In addition, C.collinus can cause respiratory symptoms; the dust of its dried resins is irritating to the nose and lungs and in one case of ingestion, pulmonary edema preceded death. C. collinus toxicity has also caused neurologic symptoms such as giddiness, seizures, coma, progressive neuromuscular weakness and paresis.
    0.2.4) HEENT
    A) WITH POISONING/EXPOSURE
    1) Eye irritation may range from simple conjunctivitis to iritis, corneal ulceration, and temporary blindness.
    2) Ingestion may cause a burning sensation of the mouth, throat, lips, and buccal surfaces. Erythema and swelling are also common findings.
    0.2.21) CARCINOGENICITY
    A) The diterpene esters found in these plants are co-carcinogenic, meaning that they promote the growth of cancers when cancer inducing agents are present. We were not able to find actual human cases where these agents were held responsible for inducing cancer.

Range Of Toxicity

    A) TOXIC DOSE: DERMAL or OCULAR: Following dermal or ocular exposure, the extent of reaction relates to the amount and duration of latex exposure. INGESTION: There are minimal reports of oral exposure. However, 2 women intentionally ingested C. collinus extract and developed persistent hypotension that was unresponsive to therapy. Serious reactions can occur after ingesting a few mouthfuls of some species while other species seem to produce minimal or no effects. The 5-deoxy-13-hydroxy-ingenol found in Mabea excelsea has a median skin irritant dose of 3.6 nanograms.

Laboratory Monitoring

    A) No specific laboratory tests exist to identify agents. In general, no specific laboratory tests are required, though if severe gastrointestinal symptoms (eg, vomiting, diarrhea) occur, measure serum electrolytes and fluid status.

Treatment Overview

    0.4.2) ORAL/PARENTERAL EXPOSURE
    A) MANAGEMENT OF MILD TO MODERATE TOXICITY
    1) For mild and moderate toxicity, supportive care is all that is needed. Large amounts of ingested latex may be treated with decontamination. However, in general, the irritant nature of the plant discourages a large ingestion. If there is no respiratory compromise, administer milk or water as soon as possible after ingestion; no more than 8 ounces (240 mL) in adults and 4 ounces (120 mL) in children to minimize the risk of emesis.
    2) DERMAL EXPOSURE: Remove contaminated clothing and jewelry and place them in plastic bags. Wash exposed areas with soap and water for 10 to 15 minutes with gentle sponging to avoid skin breakdown. Other measures used for treatment include antihistamines, steroids, and antibiotics, if there is evidence of an infection.
    3) EYE EXPOSURE: Remove contact lens and irrigate exposed eyes with copious amounts of room temperature 0.9% saline or water for at least 15 minutes. Other treatments for eye exposures include bandaging, antibiotics, atropine, and steroid ointments. Systemic antibiotics and steroids have also been used.
    B) MANAGEMENT OF SEVERE TOXICITY
    1) Severe toxicity is extremely rare. Supportive care is again the mainstay of treatment. Intubation for respiratory distress and standard ACLS treatment for cardiopulmonary arrest should be instituted. Severe gastrointestinal symptoms may require intravenous fluid hydration and electrolyte replacement.
    C) DECONTAMINATION
    1) PREHOSPITAL: There is no evidence for the use of ipecac and it is NOT recommended. Prehospital activated charcoal is unlikely to be helpful in the vast majority of ingestions. Complications from activated charcoal, such as vomiting and charcoal aspiration, could be more serious than Euphorbiaceae toxicity. Simple dilution with water or milk for ingestions could be appropriate and skin or eye exposures should be treated with initial decontamination and irrigation with water or normal saline.
    2) HOSPITAL: Activated charcoal may be considered with oral ingestions of Euphorbiaceae species with serious toxicity (eg, C. collinus) if the ingestion was recent (within an hour of ingestion). Gastric lavage, whole bowel irrigation, or multiple doses of activated charcoal is not indicated. Gastric lavage (within one hour of ingestion) in cases of catastrophic ingestion is a consideration but not a mainstay of gastric decontamination treatment and may be problematic.
    D) AIRWAY MANAGEMENT
    1) Airway management is unlikely to be necessary following exposure.
    E) ANTIDOTE
    1) There is no specific antidote for Euphorbiaceae toxicity.
    F) ENHANCED ELIMINATION
    1) There is no evidence for the use of hemodialysis, hemoperfusion, urinary alkalinization or multiple dose charcoal.
    G) PATIENT DISPOSITION
    1) HOME CRITERIA: The vast majority of cases can likely be managed at home as long as symptoms are mild and do not worsen after decontamination.
    2) OBSERVATION CRITERIA: Patients with moderate to severe or worsening symptoms should be sent to a healthcare facility for further evaluation until symptoms are stabilized. Patients can be discharged to home, if the patient is medically stable.
    3) ADMISSION CRITERIA: Patients with worsening or severe symptoms should be admitted to the hospital. Depending on the severity of their symptoms (eg, intubated, cardiac toxicity), they may require ICU care. Patients should only be discharged if they are medically stable and are clearly improving.
    4) CONSULT CRITERIA: Depending on their symptoms, other specialists may be involved (eg, intensivists for patients admitted to the ICU, cardiologists for patients with severe cardiac toxicity. A toxicologist or poison center may be contacted for treatment advice at any time for exposed patients as the vast majority may be managed by a poison center at home.
    H) PITFALLS
    1) Potential pitfalls include over treating mild exposures and not recognizing the toxicity of these plants.
    I) TOXICOKINETICS
    1) In testing 60 species of Euphorbiaceae for their degree of irritation and time of onset a mouse ear irritancy test was used; 3 major types of dermal toxicity occurred and times of onset. The first showed no irritation (E. pulcherrima (poinsettia), E. portlandica, and E. balsamifera). The second group showed maximum irritation at 4 hours that rapidly fell off over the day. Finally, the third group had maximal irritation at 24 hours.
    J) DIFFERENTIAL DIAGNOSIS
    1) Dermal and ocular exposures can mimic exposure to other irritant or blistering agents such as other chemical agents. Gastrointestinal illness can mimic other cause of food poisoning and gastrointestinal upset.
    0.4.4) EYE EXPOSURE
    A) DECONTAMINATION: Remove contact lenses and irrigate exposed eyes with copious amounts of room temperature 0.9% saline or water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist after 15 minutes of irrigation, the patient should be seen in a healthcare facility.
    B) Various methods have been used to treat eye exposures, including bandaging, antibiotic, atropine, and steroid ointments. Systemic (oral) antibiotics and steroids have also been used.
    0.4.5) DERMAL EXPOSURE
    A) OVERVIEW
    1) DECONTAMINATION: Remove contaminated clothing and jewelry and place them in plastic bags. Wash exposed areas with soap and water for 10 to 15 minutes with gentle sponging to avoid skin breakdown. A physician may need to examine the area if irritation or pain persists (Burgess et al, 1999).
    2) Decontamination is of primary importance. Other measures used to relieve the discomfort of symptoms have met with minimal success. Systemic antihistamines and steroids have been used, as have antibiotics when there was indication of infection.

Summary Of Exposure

    A) BACKGROUND: Euphorbiaceae, also known as spurges, are a family of plants found worldwide. They are used as foods, medicines, and industrial uses. As medicinal and toxic agents, they are best known for their purgative, tumor promoting and irritant properties.
    B) TOXICOLOGY: The toxicity of Euphorbiaceae depends on the specific plants of the family and the various parts of each plant. For instance, resiniferatoxin, which is an extremely potent capsaicin analog, can be found in Euphorbia resinifera and Euphorbia poissonii. Euphorbia marinata contains a ribosome inactivating protein in its latex. Tumor promotion substances include the ingenane and tigliane diterpene esters, which are also irritants.
    C) EPIDEMIOLOGY: Euphorbiaceae plants are found worldwide and thus exposures to people are extremely common. Though most plants in this family are found in tropical areas, there are species found in nontropical areas as well. Prominent plants that people may come in contact with includes cassava, castor oil plants, and poinsettias.
    D) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE EXPOSURES: Some plants in this family contain irritant diterpene esters that can be irritating. Ingestion may cause oral irritation, gastritis, vomiting and diarrhea. In addition, ingestion may cause a burning sensation of the mouth, throat, lips, and buccal surfaces. Erythema and swelling are also common. After ingesting a soup containing Breynia officinalis, hepatotoxicity was reported. The most commonly reported toxicity is dermal, due to the milky latex excreted by some of these plants that can cause contact erythema, swelling, and the formation of blisters and vesicles.
    2) SEVERE EXPOSURES: Systemic symptoms are rare but may include giddiness, electrolyte disturbances (hypokalemia), cardiac toxicity (ECG abnormalities), CNS toxicity (seizures, coma, neuromuscular weakness), renal and respiratory failure and even death. Specifically, cardiac dysrhythmias and hypotension have developed after ingestion of Cleistanthus collinus extract and leaves. In addition, C.collinus can cause respiratory symptoms; the dust of its dried resins is irritating to the nose and lungs and in one case of ingestion, pulmonary edema preceded death. C. collinus toxicity has also caused neurologic symptoms such as giddiness, seizures, coma, progressive neuromuscular weakness and paresis.

Heent

    3.4.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Eye irritation may range from simple conjunctivitis to iritis, corneal ulceration, and temporary blindness.
    2) Ingestion may cause a burning sensation of the mouth, throat, lips, and buccal surfaces. Erythema and swelling are also common findings.
    3.4.2) HEAD
    A) Eye irritation and injury are common. Mucous membrane irritation is also common.
    B) WITH POISONING/EXPOSURE
    1) Erythema and swelling may be seen on the faces of children exposed (Spoerke & Temple, 1979).
    C) ANIMAL STUDIES
    1) Cattle driven through brush containing E. ingens have developed burns of the lips, eyes, and face. Burns have occasionally been so severe as to cause death (Watt & Breyer-Brandwijk, 1962).
    3.4.3) EYES
    A) WITH POISONING/EXPOSURE
    1) KERATOPATHY/KERATOCONJUNCTIVITIS as well as temporary blindness has been reported in various references after direct contact between the irritant latex and the eye (Shlamovitz et al, 2009; Markby et al, 1989; Kingsbury, 1964; Crowder & Sexton, 1964).
    a) Hartmann (1940) reported a case where a patient developed corneal edema, conjunctival hemorrhage, serofibrinous exudate into the anterior chamber, and a vitreous haze after instillation of the latex of Euphorbia peplus. The eye healed without sequelae within 14 days.
    b) Initial contact with Euphorbia sap produced epitheliopathy with immediate burning and photophobia without visual loss. Epithelial slough delayed healing. The epithelial defect required almost 9 days for recovery. After healing there were no visual defects or loss of vision (Scott & Karp, 1996).
    c) KERACONJUNCTIVITIS: A 40-year-old man developed severe pain and rapid changes in visual acuity (right eye: 20/200; left eye 20/40 {normal vision: 20/20 bilaterally}) after contact with the sap of a pencil cactus (Euphorbia tirucalli). An ocular exam showed hyperemic conjunctivae with bilaterally diffuse punctuate opacification of the corneal epithelium. The patient was treated with repeated doses of proparacaine with only temporary pain relief. Pain was eventually managed with copious eye irrigation, topical anesthetics, steroids and antibiotic ointment. Approximately 16 hours after exposure, an ophthalmology exam showed no new symptoms and the patient was discharged to home. Long term outcome was unknown, because the patient was lost to follow-up (Shlamovitz et al, 2009).
    d) UVEITIS: A group of 7 patients with ocular exposure to various Euphorbia species (identified via a specimen of the plant) were studied for ocular effects. Initial symptoms were stinging or a burning pain in the eyes, lacrimation, photophobia, and often blurred vision. Various degrees of decreased visual acuity were noted in all patients.
    1) Ocular damage ranged from mild epithelial keratoconjunctivitis to severe keratitis with stromal edema, corneal epithelial sloughing and anterior uveitis. One to two weeks was required for resolution of the symptoms. The species involved were E. milli, E. characias, E. characias subsp. wulfenii, E. palustris, E. platyphyllos, and E. robbiae (Eke et al, 2000).
    2) IRITIS as well as lid swelling, keratitis and severe conjunctivitis has been reported when the latex of Euphorbiaceae has been placed in the eye (Lisch, 1980).
    3) BLINDNESS: Temporary blindness and intense pain has been caused by E. ingens, E. lactea, E. tirucalli, and others (Watt & Breyer-Branwijk, 1962).
    4) CORNEAL SCARRING as well as ulceration, iridocyclitis and total anterior staphyloma was seen in four cases of ocular exposure to the latex of E. royleana (Sofat et al, 1972; Sood et al, 1971).
    5) MIOSIS: Pupillary constriction was seen in a fatal case of ingestion of E. helioscopia (Vlachos et al, 1978).
    6) CONJUNCTIVITIS: A child with ocular exposure to Euphorbia myrsinites developed conjunctivitis of the right eye (Eberle et al, 1999).
    7) DIPLOPIA followed by significant PTOSIS and OCULOMOTOR PALSY was reported in a woman following ingestion of Cleistanthus collinus extract (Eswarappa et al, 2003).
    8) CASE SERIES: After a group of villagers (n=19) ingested a soup containing Breynia officinalis stems, 2 patients experienced blurred vision (Lin et al, 2003).
    B) ANIMAL STUDIES
    1) DOGS: The latex of E. lactea was tested on anesthetized dogs. Three drops of undiluted latex were placed in the eyes of the dogs and allowed to spread over the cornea and onto the conjunctiva. The eyes were not rinsed or treated in any other way.
    a) There did not appear to be any immediate reaction, but within 3 hours the eyes were red and had slight swelling of the conjunctiva. The cornea was clear. Hemorrhage and swelling of the conjunctiva, as well as a mucous discharge was seen in 7 to 12 hours.
    b) The cornea was now cloudy. For the next 18 to 24 hours the cases worsened with the peak corneal hazing appearing at 24 to 36 hours. By 48 to 72 hours there was considerable improvement.
    2) A concentration of 0.35% of the latex from Euphorbia splendens was irritating to the eyes of tested rabbits (Freitas et al, 1991).
    3.4.5) NOSE
    A) WITH POISONING/EXPOSURE
    1) SNEEZING: The dried latex of E. resinifera is very irritating and may cause violent sneezing if the dust is inhaled (Mitchell & Rook, 1979).
    3.4.6) THROAT
    A) WITH POISONING/EXPOSURE
    1) IRRITATION: Ingestion of the latex may produce a severe burning sensation of the throat (Frohne & Pfander, 1983).
    2) INCIDENCE: According to the AAPCC Toxic Exposure Surveillance System (TESS) for 1992 through 1999, 28.5% and 15% of patients experienced oral irritation and throat irritation, respectively, following Euphorbia spp. plant ingestions (Mrvos et al, 2001).

Cardiovascular

    3.5.2) CLINICAL EFFECTS
    A) LOW BLOOD PRESSURE
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 24-year-old man ingested 40 to 50 Cleistanthus collinus leaves and approximately 48 hours after admission showed evidence of toxin-induced vasodilatation (ie, hypotension, tachycardia, low CVP, oliguria and increased urinary osmolality). The patient recovered following supportive efforts including fluid and electrolyte replacement and N-acetylcysteine therapy (Benjamin et al, 2006).
    b) CASE REPORTS: Two women intentionally ingested Cleistanthus collinus extract (the liquid was extracted from crushed boiled leaves which were identified by forensic medical and toxicology experts) and developed persistent hypotension that was unresponsive to therapy (i.e., crystalloids, dopamine, norepinephrine and dobutamine). Both died following the development of pulseless electrical activity that did not respond to resuscitation efforts (Eswarappa et al, 2003).
    B) ELECTROCARDIOGRAM ABNORMAL
    1) WITH POISONING/EXPOSURE
    a) CASE REPORTS
    1) Following intentional ingestion of Cleistanthus collinus extract (the liquid was extracted from crushed boiled leaves; leaves were identified by forensic medical and toxicology experts), two women developed several electrocardiographic abnormalities, which included ST segment depression (0.5 mm in lateral chest leads - V5, V6), asystolic cardiac arrest, and finally pulseless electrical activity in both patients. Neither patient responded to aggressive resuscitation measures, and died within 52 hours and 6 days of exposure, respectively (Eswarappa et al, 2003).
    C) TIGHT CHEST
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: After a group of villagers (n=19) ingested a soup containing Breynia officinalis stems, 4 and 7 patients experienced chest tightness and palpitation, respectively (Lin et al, 2003).

Respiratory

    3.6.2) CLINICAL EFFECTS
    A) IRRITATION SYMPTOM
    1) WITH POISONING/EXPOSURE
    a) Synadendium cupulare is a known irritant and vesicant. The vapors given off by the plant are said to be irritant and may produce effects even when held at arm's length (Mitchell & Rook, 1979).
    B) ACUTE LUNG INJURY
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Increasing hypoxia, dyspnea, tachypnea, and bilateral peripheral alveolar infiltrates on chest x-ray were observed in a 24-year-old man after ingesting 40 to 50 Cleistanthus collinus leaves. Mechanical ventilation with PEEP were used to manage his ARDS. The patient was extubated on hospital day 10 and lung shadows disappeared within 3 weeks (Benjamin et al, 2006).
    b) CASE REPORT: Pulmonary edema was reported in one fatal case where a child sucked on the latex of E. helioscopia (Vlachos et al, 1978). Most exposures do not result in serious pulmonary symptoms.
    C) RESPIRATORY FAILURE
    1) WITH POISONING/EXPOSURE
    a) Respiratory failure requiring mechanical ventilation was reported secondary to progressive neuromuscular weakness following an ingestion of Cleistanthus collinus extract (the liquid was extracted from crushed boiled leaves; leaves were identified by forensic medical and toxicology experts). The patient died from cardiac toxicity 6 days after exposure (Eswarappa et al, 2003).
    D) RESPIRATORY FINDING
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: After a group of villagers (n=19) ingested a soup containing Breynia officinalis stems, dyspnea (n=1) and tachypnea (n=1) were reported (Lin et al, 2003).

Neurologic

    3.7.2) CLINICAL EFFECTS
    A) CENTRAL NERVOUS SYSTEM FINDING
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: After a group of villagers (n=19) ingested a soup containing Breynia officinalis stems, vertigo (n=3), malaise (n=2), tremor (n=2), headache (n=2), drowsiness (n=1) were reported (Lin et al, 2003).
    B) SEIZURE
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Seizures were seen in a child who ingested the latex of E. helioscopia (Vlachos et al, 1978). Most cases do not result in serious neurologic symptoms.
    C) COMA
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Coma preceded death in a fatal case of ingestion of E. helioscopia (Vlachos et al, 1978).
    D) DIZZINESS
    1) WITH POISONING/EXPOSURE
    a) GIDDINESS: May be seen in cases of ingestion (Frohne & Pfander, 1983).
    E) FLACCID PARALYSIS
    1) WITH POISONING/EXPOSURE
    a) Progressive neuromuscular weakness and hyporeflexic flaccid quadriparesis was reported in a woman following intentional ingestion of Cleistanthus collinus extract (the liquid was extracted from crushed boiled leaves; leaves were identified by forensic medical and toxicology experts). The patient died from cardiac toxicity 6 days after exposure (Eswarappa et al, 2003).

Gastrointestinal

    3.8.2) CLINICAL EFFECTS
    A) EDEMA
    1) WITH POISONING/EXPOSURE
    a) Oral exposure to Syndendium grantii has caused swelling of the lips, erythema, of the mouth, and increased drooling (Spoerke et al, 1985; Vlachos et al, 1978).
    B) GASTROINTESTINAL IRRITATION
    1) WITH POISONING/EXPOSURE
    a) Individuals who ingested the caper spurge (E. lathyris) have developed a severe burning sensation of the mouth and throat (Mitchell & Rook, 1979).
    C) NAUSEA AND VOMITING
    1) WITH POISONING/EXPOSURE
    a) Vomiting has been reported when the resin from E. resinifera and Hippomane mancinella has been ingested (Mitchell & Rook, 1979; Caddy, 1894). It has also been reported following ingestion of Cleistanthus collinus extract (from the leaf of the plant) (Eswarappa et al, 2003).
    b) CASE SERIES: After a group of villagers (n=19) ingested a soup containing Breynia officinalis stems, 10 and 7 patients experienced nausea and vomiting, respectively (Lin et al, 2003).
    c) INCIDENCE: Nausea and vomiting have been reported in 4.4% and 24% of patients following Euphorbia spp. plant ingestions, according to the AAPCC TESS for 1992 through 1999 (Mrvos et al, 2001).
    D) DIARRHEA
    1) Diarrhea has been reported when the resin from E. resinifera and Hippomane mancinella has been ingested (Mitchell & Rook, 1979; Caddy, 1894). It has also been reported following the ingestion of Cleistanthus collinus extract (from the leaf of the plant) (Eswarappa et al, 2003).
    2) CASE SERIES: After a group of villagers (n=19) ingested a soup containing Breynia officinalis stems, 14 patients experienced diarrhea (Lin et al, 2003).
    3) Diarrhea, which may be bloody, followed by severe gastritis, may be seen after ingestion of plants containing the diterpene esters such as Hippomane manacinella (Lampe & McCann, 1985).
    E) ABDOMINAL PAIN
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: After a group of villagers (n=19) ingested a soup containing Breynia officinalis stems, 3 and 9 patients experienced abdominal pain and fullness, respectively (Lin et al, 2003).
    F) APTYALISM
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: After a group of villagers (n=19) ingested a soup containing Breynia officinalis stems, 6 patients experienced dry mouth (Lin et al, 2003).
    G) DECREASE IN APPETITE
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: After a group of villagers (n=19) ingested a soup containing Breynia officinalis stems, 5 patients experienced poor appetite (Lin et al, 2003).
    H) HEARTBURN
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: After a group of villagers (n=19) ingested a soup containing Breynia officinalis stems, 4 and 1 patients experienced heartburn and belching, respectively (Lin et al, 2003).
    I) TASTE SENSE ALTERED
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: After a group of villagers (n=19) ingested a soup containing Breynia officinalis stems, one patient experienced bitter taste in the mouth (Lin et al, 2003).

Hepatic

    3.9.2) CLINICAL EFFECTS
    A) INJURY OF LIVER
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: In one case series, 18 of 19 patients (11 men and 8 women) developed abnormal liver function tests (LFT) after ingesting an average of 130 mL (30 to 900 mL) of soup containing Breynia officinalis stems. Diarrhea, nausea and chilly sensations, abdominal fullness, and vomiting were reported by 14, 10, 9, and 7 patients, respectively. The observed maximum median level of ALT was 647 Units/L (range 89-9440 Units/L), AST 314 Units/L (range: 47 to 7756 Units/L), alkaline phosphatase 251 Units/L (range: 224 to 278 Units/L), gamma glutamyl transpeptidase 106 Units/L (range: 84 to 313 Units/L), total bilirubin 2.2 (1.6 to 2.8), and direct bilirubin 0.5 (0.5 to 0.8). One patient who ingested 60 mL of the soup (the smallest amount) did not develop abnormal LFTs. When hepatitis markers were measured, 5 of the 18 patients who developed abnormal LFTs were positive for HBsAg and 2 were positive for anti-HCVAb. Three of the 5 patients with abnormal total and direct bilirubin were also positive for HBsAG and one was positive for anti-HCVAb. Following supportive therapy, all liver function abnormalities resolved within 6 months of exposure (Lin et al, 2003).

Genitourinary

    3.10.2) CLINICAL EFFECTS
    A) ACUTE RENAL FAILURE SYNDROME
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 29-year-old man with a history of stable nephrotic syndrome developed acute renal failure after the ingestion of Euphorbia paralias (ie, boiled the plant) as a herbal treatment for edema approximately 10 days prior to admission. Initial laboratory studies included a serum creatinine of 1835 micromol/L and urea of 44.6 mmol/L and severe hypoproteinemia. An ultrasound showed enlarged kidneys and a renal biopsy was positive for glomerulosclerosis and associated with acute tubular injury. Treatment included intermittent hemodialysis and corticosteroid therapy; urinary volume and creatinine normalized over 48 days. Six months later the patient still had an elevated serum creatinine (240 micromol/L) (Boubaker et al, 2013).
    b) CASE REPORT: Acute renal failure developed in a fatal exposure to an ingestion of Cleistanthus collinus extract (the liquid was extracted from crushed boiled leaves which were identified by forensic medical and toxicology experts) in a woman (Eswarappa et al, 2003). Along with elevations in BUN and serum creatinine, the patient developed polyuria (3450 mL of urine over 22 hours) approximately 5 days after exposure. This was followed by progressive oliguria (250 mL over 14 hours) until her death from cardiac toxicity.
    B) RENAL TUBULAR ACIDOSIS
    1) WITH POISONING/EXPOSURE
    a) Renal tubular acidosis (ie, increased potassium loss, hyperchloremic metabolic acidosis, and normal serum anion gap) occurred in a 24-year-old man after ingesting 40 to 50 Cleistanthus collinus leaves. The diagnosis was confirmed by a positive urinary anion gap despite low serum bicarbonate. Treatment included IV sodium bicarbonate to correct acidosis, followed by Shohl's solution and potassium citrate by Ryle's tube. The patient was also treated with N-acteylcysteine and distal RTA improved over a 2 week period. The patient made a complete recovery (Benjamin et al, 2006). Distal renal tubular acidosis was also suspected in another patient with Cleistanthus collinus toxicity (Eswarappa, 2007).
    C) OLIGURIA
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: After a group of villagers (n=19) ingested a soup containing Breynia officinalis stems, one patient experienced oliguria (Lin et al, 2003). In another case, an adult ingested 40 to 50 Cleistanthus collinus leaves and developed oliguria (Benjamin et al, 2006).
    D) COLOR OF URINE
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: After a group of villagers (n=19) ingested a soup containing Breynia officinalis stems, one patient experienced tea-colored urine (Lin et al, 2003).

Acid-Base

    3.11.2) CLINICAL EFFECTS
    A) METABOLIC ACIDOSIS
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Metabolic acidosis was observed in a 24-year-old man after ingesting 40 to 50 Cleistanthus collinus leaves. Cardiac toxicity, distal renal tubular acidosis and ARDS were also present. The patient recovered following supportive care which included mechanical ventilation and N-acteylcysteine therapy (Benjamin et al, 2006).
    b) CASE REPORTS: Metabolic acidosis was reported in two fatal cases of intentional Cleistanthus collinus extract ingestion (patients drank liquid extracted from crushed boiled leaves). In one patient, life-threatening metabolic acidosis, along with cardiac and neuromuscular toxicity did not occur until approximately 4 days after exposure. The other patient died within 52 hours of exposure (Eswarappa et al, 2003).

Hematologic

    3.13.2) CLINICAL EFFECTS
    A) PLATELET AGGREGATION
    1) WITH POISONING/EXPOSURE
    a) PLATELET AGGREGATION: The toxin of Mabea excelsea (esters of 5-deoxy-13-hydroxy-ingenol) have the ability to induce human platelet aggregation at a median dose of 2.4 mcg/mL (Markby et al, 1989).
    B) LEUKOCYTOSIS
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: After a group of villagers (n=19) ingested a soup containing Breynia officinalis stems, 2 patients developed a transient leukocytosis [WBC 25,200/mm(3) and 16,600/mm(3)] with neutrophil counts as high as 87.6% and 88.9% the first day after exposure, returning to normal 4 days after the ingestions (Lin et al, 2003).

Dermatologic

    3.14.2) CLINICAL EFFECTS
    A) FLUSHING
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: After a group of villagers (n=19) ingested a soup containing Breynia officinalis stems, one patient experienced flushing (Lin et al, 2003).
    B) BULLOUS ERUPTION
    1) WITH POISONING/EXPOSURE
    a) SKIN LESIONS: Contact with the irritant latex may produce blisters and lesions that are then open to secondary infection (Markby et al, 1989; Kinghorn, 1980; Kinghorn & Evans, 1975).
    b) TYPICAL PRESENTATION
    1) In most cases there is no immediate discomfort, but in about 4 hours there may be a burning sensation of the affected area. Within 8 hours this sensation may be severe and red streaking and blistering may appear. A fine papular rash, vesicles, or large bullae may be seen (Calnan, 1975).
    2) The erythema usually subsides within the first 48 hours, but the blisters may not be healed for 4 to 7 days (Spoerke et al, 1985; Spoerke & Temple, 1979; Rook, 1965).
    3) CASE SERIES: The undiluted latex of the ornamental succulent plant Euphorbia hermentiana was tested on 5 Caucasian subjects. Follicular dermatitis was noted when the latex was used in an open test on the flexor forearm. Bullae, vesiculation (with desquamation and hyperpigmentation) was observed in closed testing on the flexor surfaces of the upper arms. Signs of irritation remained for over a week (Worobec et al, 1981).
    3.14.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) SKIN NECROSIS
    a) INJECTION of the latex from Synadenium into the skin of guinea pigs produced necrosis and sloughing (Thorold, 1953).
    2) IRRITATION
    a) Dermal exposure to the latex of Euphorbia splendens was irritating to the skin of rabbits in concentrations greater than 0.5% (Freitas et al, 1991).

Musculoskeletal

    3.15.2) CLINICAL EFFECTS
    A) PAIN
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: After a group of villagers (n=19) ingested a soup containing Breynia officinalis stems, muscle pain (n=1), bone pain (n=1) and lumbar soreness (n=1) were reported (Lin et al, 2003).
    B) SERUM CREATININE RAISED
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: An elevated serum creatinine kinase (total 883 Units/L and CK-MB 123 U/L) concentration was reported in a 24-year-old man after ingesting 40 to 50 Cliestanthus collinus leaves (Benjamin et al, 2006).

Endocrine

    3.16.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) ENDOCRINE DISORDER
    a) PROGESTIN: In vitro studies of the phorbol ester TPA on gonadotropin stimulated steroidogenesis in primary cultures of rat ovarian granulosa and testicular Leydig cells showed inhibition of progestin biosynthesis and decreases in FSH-stimulated pregnenolone biosynthesis (Welsh et al, 1984).
    b) PROLACTIN: In vitro treatment of pituitary tumor cells with the phorbol ester TPA increases prolactin and decreases growth hormone secretion by these cells (Osborne & Tashijan, 1981; Jaken et al, 1981; Blumberg, 1980).
    c) INSULIN: The secretion of insulin was stimulated by the phorbol ester TPA (Malaisse et al, 1980; Blumberg, 1980) (Virgi et al, 1978).
    d) LH LEVELS: In cultured rat pituitary cells were increased by treatment with TPA, as was adrenocorticotropic hormone secretion (Naor & Catt, 1981; Smith & Vale, 1980).

Immunologic

    3.19.2) CLINICAL EFFECTS
    A) ACUTE ALLERGIC REACTION
    1) WITH POISONING/EXPOSURE
    a) Specific IgE was found in the serum of subjects who developed severe urticaria- type, pruritic, allergic reactions at the site of contact with Euphorbias characias latex. In three of seven subjects, the pruritus was generalized. Examination of the latex did not find phorbol or ingenol derivatives. Prick tests with the latex were positive (Ballero et al, 1999).
    b) Occupational allergy due to exposure to the pollen of Euphorbia fulgens has been reported in growers. Symptoms included tracheobronchitis or bronchial asthma. Intracutaneous tests for allergy were done using pollen extracts. The subjects were positive even in high dilution. The allergen was found only in the pollen, not in the latex or other parts of the plant (Hausen et al, 1976).

Carcinogenicity

    3.21.2) SUMMARY/HUMAN
    A) The diterpene esters found in these plants are co-carcinogenic, meaning that they promote the growth of cancers when cancer inducing agents are present. We were not able to find actual human cases where these agents were held responsible for inducing cancer.
    3.21.3) HUMAN STUDIES
    A) CARCINOMA
    1) COCARCINOGENIC ACTIVITY - Has been seen with many of the diterpene esters found in the Euphorbiaceae (Zayed et al, 2001; (Hecker, 1976; Berenblum, 1975). These chemicals promote the growth of tumors induced by a carcinogen.
    2) Most of the experiments involving the carcinogenic effects have been done in animals, and experiments proving these effects in humans are lacking (Kinghorn, 1979).
    B) NEOPLASM
    1) Repeated applications of a tumor-promoting chemical to the skin may lead to hyperplasia but not necessarily to cancer (Boutwell, 1974).
    3.21.4) ANIMAL STUDIES
    A) CARCINOMA
    1) COCARCINOGENIC ACTIVITY - Has been seen with many of the diterpene esters found in the Euphorbiaceae (Zayed et al, 2001; (Hecker, 1976; Berenblum, 1975). These chemicals promote the growth of tumors induced by a carcinogen.
    2) Most of the experiments involving the carcinogenic effects have been done in animals, and experiments proving these effects in humans are lacking (Kinghorn, 1979).
    B) NEOPLASM
    1) ANTITUMOR PRINCIPLES - Have also been isolated. An extract from Euphorbia lathyris (L.) showed antineoplastic activity against sarcoma 180 ascites in mice. It appears the active agent was ingenol-3-hexadecanoate (Itokawa et al, 1989).

Monitoring Parameters Levels

    4.1.1) SUMMARY
    A) No specific laboratory tests exist to identify agents. In general, no specific laboratory tests are required, though if severe gastrointestinal symptoms (eg, vomiting, diarrhea) occur, measure serum electrolytes and fluid status.
    4.1.2) SERUM/BLOOD
    A) BLOOD/SERUM CHEMISTRY
    1) No specific laboratory test are required. If vomiting and diarrhea are persistent, measure serum electrolytes and fluid status.

Life Support

    A) Support respiratory and cardiovascular function.

Patient Disposition

    6.3.1) DISPOSITION/ORAL EXPOSURE
    6.3.1.1) ADMISSION CRITERIA/ORAL
    A) Patients with worsening or severe symptoms should be admitted to the hospital. Depending on the severity of their symptoms (eg, intubated, cardiac toxicity), they may require ICU care. Patients should only be discharged if they are medically stable and are clearly improving.
    6.3.1.2) HOME CRITERIA/ORAL
    A) The vast majority of cases can likely be managed at home as long as symptoms are mild and do not worsen after decontamination.
    6.3.1.3) CONSULT CRITERIA/ORAL
    A) Depending on their symptoms, other specialists may be involved (eg, intensivists for patients admitted to the ICU, cardiologists for patients with severe cardiac toxicity. A toxicologist or poison center may be contacted for treatment advice at any time for exposed patients as the vast majority may be managed by a poison center at home.
    6.3.1.5) OBSERVATION CRITERIA/ORAL
    A) Patients with moderate to severe or worsening symptoms should be sent to a healthcare facility for further evaluation until symptoms are stabilized. Patients can be discharged to home, if the patient is medically stable.

Monitoring

    A) No specific laboratory tests exist to identify agents. In general, no specific laboratory tests are required, though if severe gastrointestinal symptoms (eg, vomiting, diarrhea) occur, measure serum electrolytes and fluid status.

Oral Exposure

    6.5.1) PREVENTION OF ABSORPTION/PREHOSPITAL
    A) SUMMARY
    1) Prehospital activated charcoal is unlikely to be helpful in the vast majority of ingestions. The irritant nature of the plant discourages a large ingestion. Complications from activated charcoal, such as vomiting and charcoal aspiration, could be more serious than Euphorbiaceae toxicity. Simple dilution with water or milk for ingestions could be appropriate and skin or eye exposures should be treated with initial decontamination and irrigation with water or normal saline.
    B) DILUTION
    1) DILUTION: If no respiratory compromise is present, administer milk or water as soon as possible after ingestion. Dilution may only be helpful if performed in the first seconds to minutes after ingestion. The ideal amount is unknown; no more than 8 ounces (240 mL) in adults and 4 ounces (120 mL) in children is recommended to minimize the risk of vomiting (Caravati, 2004).
    6.5.2) PREVENTION OF ABSORPTION
    A) INDICATIONS
    1) If small amounts are ingested, dilution is probably all that is required. Larger ingestions may benefit from the administration of activated charcoal, if the ingestion was recent.
    B) DILUTION
    1) DILUTION: If no respiratory compromise is present, administer milk or water as soon as possible after ingestion. Dilution may only be helpful if performed in the first seconds to minutes after ingestion. The ideal amount is unknown; no more than 8 ounces (240 mL) in adults and 4 ounces (120 mL) in children is recommended to minimize the risk of vomiting (Caravati, 2004).
    C) ACTIVATED CHARCOAL
    1) CHARCOAL ADMINISTRATION
    a) Consider administration of activated charcoal after a potentially toxic ingestion (Chyka et al, 2005). Administer charcoal as an aqueous slurry; most effective when administered within one hour of ingestion.
    2) CHARCOAL DOSE
    a) Use a minimum of 240 milliliters of water per 30 grams charcoal (FDA, 1985). Optimum dose not established; usual dose is 25 to 100 grams in adults and adolescents; 25 to 50 grams in children aged 1 to 12 years (or 0.5 to 1 gram/kilogram body weight) ; and 0.5 to 1 gram/kilogram in infants up to 1 year old (Chyka et al, 2005).
    1) Routine use of a cathartic with activated charcoal is NOT recommended as there is no evidence that cathartics reduce drug absorption and cathartics are known to cause adverse effects such as nausea, vomiting, abdominal cramps, electrolyte imbalances and occasionally hypotension (None Listed, 2004).
    b) ADVERSE EFFECTS/CONTRAINDICATIONS
    1) Complications: emesis, aspiration (Chyka et al, 2005). Aspiration may be complicated by acute respiratory failure, ARDS, bronchiolitis obliterans or chronic lung disease (Golej et al, 2001; Graff et al, 2002; Pollack et al, 1981; Harris & Filandrinos, 1993; Elliot et al, 1989; Rau et al, 1988; Golej et al, 2001; Graff et al, 2002). Refer to the ACTIVATED CHARCOAL/TREATMENT management for further information.
    2) Contraindications: unprotected airway (increases risk/severity of aspiration) , nonfunctioning gastrointestinal tract, uncontrolled vomiting, and ingestion of most hydrocarbons (Chyka et al, 2005).
    6.5.3) TREATMENT
    A) SUPPORT
    1) MANAGEMENT OF MILD TO MODERATE TOXICITY
    a) For mild and moderate toxicity, supportive care is all that is needed. Large amounts of ingested latex may be treated with decontamination. However, in general, the irritant nature discourages a large ingestion. If there is no respiratory compromise, administer milk or water as soon as possible after ingestion; no more than 8 ounces (240 mL) in adults and 4 ounces (120 mL) in children to minimize the risk of emesis.
    2) MANAGEMENT OF SEVERE TOXICITY
    a) Severe toxicity is extremely rare. Supportive care is again the mainstay of treatment. Intubation for respiratory distress and standard ACLS treatment for cardiopulmonary arrest should be instituted. Severe gastrointestinal symptoms may require intravenous fluid hydration and electrolyte replacement.
    B) MONITORING OF PATIENT
    1) No specific laboratory tests exist to identify agents. In general, no specific laboratory tests are required, though if severe gastrointestinal symptoms (eg, vomiting, diarrhea) occur, measure serum electrolytes and fluid status.
    C) FLUID/ELECTROLYTE BALANCE REGULATION
    1) Replace fluids and electrolytes if vomiting and diarrhea are extensive.
    D) EXPERIMENTAL THERAPY
    1) N-acetylcysteine and thiol-containing compounds have been suggested as potential antidotes in the treatment of Cleistanthus collinus ingestion (Eswarappa et al, 2003) .
    a) N-ACETYLCYSTEINE/CASE REPORT: A 24-year-old man ingested 40 to 50 Cleistanthus collinus leaves and developed severe toxicity (ie, cardiac toxicity, distal renal tubular acidosis, and ARDS) and was initially treated with supportive care. Approximately 48 hours after admission the patient was given N-acetylcysteine 150 mg/kg over one hour, followed by 50 mg/kg over 4 hours, and 100 mg/kg over 16 hours. Within one week, cardiac and liver enzymes improved, at 10 days mechanical ventilation was removed, and at 2 weeks distal renal tubular acidosis resolved (Benjamin et al, 2006). It is impossible to assess whether NAC contributed to the patient's improvement.

Inhalation Exposure

    6.7.1) DECONTAMINATION
    A) Care should be taken to wear a mask or other protective gear if handling dried powdered materials from Euphorbia species.

Eye Exposure

    6.8.1) DECONTAMINATION
    A) Instill local anesthetic as necessary and repeat for pain control. Complete ocular exam.
    B) EYE IRRIGATION, ROUTINE: Remove contact lenses and irrigate exposed eyes with copious amounts of room temperature 0.9% saline or water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist after 15 minutes of irrigation, an ophthalmologic examination should be performed (Peate, 2007; Naradzay & Barish, 2006).
    C) Continuous irrigation (a total of 2 liters over 90 minutes) with normal saline was performed on an adult who developed severe pain along with rapid changes in visual acuity after contact with the sap of a pencil cactus (Euphorbia tirucalli). Pain was eventually managed with copious eye irrigation, topical anesthetic (i.e., proparacaine), steroids and antibiotic ointment. Symptoms gradually improved over 16 hours (Shlamovitz et al, 2009).
    6.8.2) TREATMENT
    A) CORTICOSTEROID
    1) STEROIDS: The local and systemic application of corticosteroids have been recommend in mild to moderate cases. Treat conjunctival and corneal injury with topical steroids and antibiotic ointment (Shlamovitz et al, 2009). Intravenous injection of steroids has been used in severe cases (Lisch, 1980).
    B) ADMINISTRATION OF ANTIBIOTIC
    1) ANTIBIOTICS have been used in a limited number of cases of corneal and conjunctival damage (Shlamovitz et al, 2009; Eke et al, 2000; Scott & Karp, 1996; Sofat et al, 1972). Treat conjunctival and corneal injury with topical steroids and antibiotic ointment (Shlamovitz et al, 2009).
    2) In some cases, the antibiotics were both local and systemic. Atropine ointment and systemic steroids were also used
    3) These measures, along with regular and pressure bandaging, helps to relieve the symptoms, but did not reduce the residual effects (Eke et al, 2000; Scott & Karp, 1996; Sofat et al, 1972).
    C) COMPLEMENTARY THERAPY
    1) In the Canary Islands, when the latex of these plants are accidentally placed in the eye, a drop of sap from Aeonium lindleyl is also applied to the eye to give some relief. This plant is a member of the Crassulaceae.
    2) Another member of this family is Sempervivum tectorum, which has also been used as a household remedy for eye inflammations caused by the Euphorbiaceae (Lisch, 1980). Scientific investigations as to the effectiveness of these plants have not been done.
    D) Treatment should include recommendations listed in the ORAL EXPOSURE section when appropriate.

Dermal Exposure

    6.9.1) DECONTAMINATION
    A) Decontamination is very important. Since the reaction is not immediate, much, if not all, of the reaction may be avoided if the latex is removed from the skin. Wash the affected area with soap and water, do not just rinse the material from the skin.
    6.9.2) TREATMENT
    A) ANTIBIOTIC
    1) In cases where infection is probable, systemic antibiotics may be indicated.
    B) ANTIHISTAMINE
    1) Systemic administration of antihistamines has been of minimal and inconsistent benefit. For some patients it provides some relief, and in some children it provides sedation during the acute phases.
    C) CORTICOSTEROID
    1) Systemic steroids have been of some value in more severe cases.
    D) Treatment should include recommendations listed in the ORAL EXPOSURE section when appropriate.

Case Reports

    A) ADULT
    1) A 42-year-old man was cutting candelabra cactus (E. lactea) when a drop of the latex was instilled in his eye. He felt an immediate stinging and burning sensation, and immediately irrigated the eye with water. The burning sensation increased over the next few hours. He was seen by an ophthalmologist within two hours. At this time he had mild conjunctival hyperemia and punctate staining of the cornea. Treatment was with a drop of tetracaine and administration of cortisone ointment. Sixteen hours after the accident, the patient awoke with copious mucous discharge, marked conjunctival edema with injection, swollen lids, and severe pain in and near the eye. Slit lamp examination showed a slough of corneal epithelium and moderate corneal striae with edema. At sixty hours post accident, the eye was no longer painful, and the corneal epithelium had started to regenerate. There was marked decrease in chemosis of the lids and conjunctiva and slight striae and edema of the cornea. The anterior chamber and vitreous were still filled with cells and there was a marked decrease in visual acuity. His condition gradually improved, so that at 19 days post exposure the eye was not painful, but visual acuity was still depressed. At 26 days the eye appeared to be normal and at one year there were no sequelae (Crowder & Sexton, 1964).
    B) PEDIATRIC
    1) A 4-year-old child was seen rubbing the milky latex of Euphorbia myrsinites on his face and into his eyes. He complained of slight irritation at that time, and his face was rinsed off, but not washed. Within 3 hours, areas of erythema, swelling, and blisters developed around the mouth, and his eyes became injected and swollen. Within 24 hours, the areas of edema had decreased, and most of the blisters had crusted. Two days after this, the child was essentially normal, except for crusted blisters (Spoerke & Temple, 1979).
    2) Euphorbia helioscopia was said to have caused the death of one of two children who sucked on the latex. Symptoms included a burning sensation of the mouth, throat, esophagus, and stomach. Salivation, stomach pain, and vomiting also occurred. There was constriction of the pupils, seizures, and pulmonary edema. Coma preceded death (Vlachos et al, 1978).

Summary

    A) TOXIC DOSE: DERMAL or OCULAR: Following dermal or ocular exposure, the extent of reaction relates to the amount and duration of latex exposure. INGESTION: There are minimal reports of oral exposure. However, 2 women intentionally ingested C. collinus extract and developed persistent hypotension that was unresponsive to therapy. Serious reactions can occur after ingesting a few mouthfuls of some species while other species seem to produce minimal or no effects. The 5-deoxy-13-hydroxy-ingenol found in Mabea excelsea has a median skin irritant dose of 3.6 nanograms.

Minimum Lethal Exposure

    A) INGESTION
    1) CASE REPORTS: Two women intentionally ingested Cleistanthus collinus extract and developed persistent hypotension that was unresponsive to therapy. Both died following pulseless electrical activity that did not respond to resuscitation efforts (Eswarappa et al, 2003).

Maximum Tolerated Exposure

    A) ROUTE OF EXPOSURE
    1) INGESTION
    a) Reports of oral toxicity are minimal. Serious reactions have occurred with just a few mouthfuls of some species, while other species , such as E. myrsinites, seen to have minimal effect, and poinsettia has almost no effect.
    2) DERMAL
    a) There is no specific toxic dose. The amount of material on the skin will determine the extent of the reaction.
    b) The 5-deoxy-13-hydroxy-ingenol (6 esters) found in Mabea excelsea have a median skin irritant dose (ID50) of 3.6 nanograms.
    3) OCULAR
    a) CASE REPORT: Acute keratoconjunctivitis with persistent severe pain, as well as rapid changes in visual acuity (right eye: 20/200; left eye 20/40 {normal vision: 20/20 bilaterally}) occurred in an adult after contact with the sap of a pencil cactus (Euphorbia tirucalli). Pain was eventually managed with copious eye irrigation, topical anesthetics, steroids, and antibiotic ointment. Symptoms gradually improved over 16 hours, but the patient was lost to follow-up (Shlamovitz et al, 2009).

Toxicologic Mechanism

    A) The receptor site of the phorbol ester is thought to be the protein kinase C (PKC) (Ellis et al, 1987; Yeh et al, 1987), where they substitute for the endogenous mediator diacylglycerol in activating PKC.
    1) This activation leads to the phosphorylation of other proteins used in various physiological processes (Markby et al, 1989; Kikkawa et al, 1983).
    B) Although structurally related to the phorbol esters, resiniferatoxin (RTX) acts as an ultra-potent capsaicin analog (Szallasi et al, 1989).
    C) Euphorbia marginata: Contains in its latex a ribosome inactivating protein. It is a single chain protein with an isoelectric point of 4.1 and a molecular weight of 105,000. It has also been shown to be hemagglutinating toward rabbit erythrocytes (Lu & Yuan, 1990).
    D) Tumor promotion: Diterpene esters of the ingenane and tigliane types are not only irritants, but also considered moderate tumor promoters (conditional carcinogens) (Zayed et al, 2001).
    E) Cleistanthus collinus (plant) toxicity is attributable to arylnaphthalene lignan lactones diphyllin (and its glycosides cleistanthin A and cleistanthin B) and collinusin. Cleistanthin A is able to inhibit DNA synthesis and induce DNA damage and apoptosis (Eswarappa et al, 2003).
    F) Inhibition of thiol or thiol-dependent enzymes, specifically lactate dehydrogenase and cholinesterase have been observed in animal models. In addition, glutathione depletion and adenosine triphosphatase inhibition in liver, kidney, heart, brain and skeletal muscles have occurred. In general, the toxicity reported with C. Collinus is likely attributed to cytotoxic effects of lactones on a number of cellular, tissue, and organ systems (Eswarappa et al, 2003).

Treatment

    11.2.1) SUMMARY
    A) GENERAL
    1) Although grazing animals generally do not seek out Euphorbia species, some of the younger plants are ingested, especially when other plants are not readily available. The toxicity is not lost with drying, so hay containing these materials is still potentially toxic (Kingsbury, 1964).

Continuing Care

    11.4.1) SUMMARY
    11.4.1.2) DECONTAMINATION/TREATMENT
    A) GENERAL
    1) Although grazing animals generally do not seek out Euphorbia species, some of the younger plants are ingested, especially when other plants are not readily available. The toxicity is not lost with drying, so hay containing these materials is still potentially toxic (Kingsbury, 1964).

Clinical Effects

    11.1.2) BOVINE/CATTLE
    A) BURNS - Cattle driven through brush have developed burns of the face, lips, and eyes. Symptoms have become serious enough in some cases to cause death (Watt & Breyer-Brandwijk, 1962).
    B) E. CYPRAISSIAS - When ingested as a large contaminate in hay, caused cattle to develop scours, collapse, and death (Kingsbury, 1964).
    C) E. HELIOSCOPIA - Two and one half pounds of partially dried sun spurge was said to be fatal in a calf fed this material experimentally (Hurst, 1942).
    D) E. MARGINATA - The latex of this plant has been used to brand cattle instead of a hot iron. When 100 grams of this plant was experimentally fed to cattle, it produced severe scours and emaciation of the animals which lasted for several months (Sperry OE, Dollahite JW & Morrow J et al, 1955).
    E) E. PEPULUS - Hurst feed this material to calves, and produced excessive salivation and blood-stained feces (Hurst, 1942).
    F) E. PROSTRATA - E. Prostrata is thought to have an effect in cattle similar to that of E. marginata.
    11.1.5) EQUINE/HORSE
    A) E. ESULA - The newly cut plants were reported to produce inflammation and hair loss on horses feet during haying (Kingsbury, 1964).
    11.1.9) OVINE/SHEEP
    A) E. ESULA has caused death in sheep (Kingsbury, 1964).
    B) E. HELIOSCOPIA caused irritation and swelling of the tongue and mouth of lambs who grazed on this material (Forsyth, 1954).
    C) E. MACULATA has been responsible for photosensitization in lambs of the southeastern United States (Case, 1957). This plant is highly toxic in sheep, death being produced by as little as 0.62% of a lamb's weight. Death occurred in a few hours (Kingsbury, 1964).
    11.1.13) OTHER
    A) OTHER
    1) ANIMAL SUMMARY - Evaluation of animal studies must be done with some care, since individual sensitivities vary considerably. This applies to both skin and eye irritation.
    a) For example, the latex of E. lathyrus, while a serious irritant to the eyes of man and guinea pigs, is not irritating to rabbits or dogs (Frohne & Pfander, 1983).

General Bibliography

    1) Adolf W, Hecker E, & Becker H: Macrocyclic lathyrane type diterpene esters (jolkinols) from callus cultures and roots of Euphorbia lathyris. Planta Medica 1984; 259-261.
    2) Ballero M, Piu G, & Appendino G: Immediate urticaria to Euphorbiaceae. Allergy 1999; 54:91-92.
    3) Benjamin SP, Fernando ME, Jayanth JJ, et al: Cleistanthus collinus poisoning. J Assoc Physicians India 2006; 54:742-744.
    4) Berenblum I: Sequential aspect of chemical carcinogenesis: skin, in Becker F (ed): Cancer Etiology, Vol 1, Chemical Carcinogenesis, Plenum Press, New York, NY, 1975.
    5) Blumberg PM: In vitro studies on the mode of action of the phorbol esters, potent tumor promoters: Part II. CRC Crit Rev Toxicol 1980; 9:199-234.
    6) Boubaker K, Ounissi M, Brahmi N, et al: Acute renal failure by ingestion of Euphorbia paralias. Saudi J Kidney Dis Transpl 2013; 24(3):571-575.
    7) Boutwell R: The function and mechanisms of promoters of carcinogenesis. CRC Crit Rev Toxicol 1974; 2:419-443.
    8) Burgess JL, Kirk M, Borron SW, et al: Emergency department hazardous materials protocol for contaminated patients. Ann Emerg Med 1999; 34(2):205-212.
    9) Caddy DJ: Poisoning by manchineal. Lancet 1894; 2:1478-1479.
    10) Calnan CD: Petty spurge (Euphorbia peplus L.). Contact Dermatitis 1975; 1:128.
    11) Caravati EM: Alkali. In: Dart RC, ed. Medical Toxicology, Lippincott Williams & Wilkins, Philadelphia, PA, 2004.
    12) Case AA: Photosensitization syndrome in cattle, sheep, and swine. N American Vet 1957; 38:161.
    13) Chyka PA, Seger D, Krenzelok EP, et al: Position paper: Single-dose activated charcoal. Clin Toxicol (Phila) 2005; 43(2):61-87.
    14) Cooper MR & Johnson AW: Poisonous Plants in Britain. Ministry of Agriculture Fisheries and Food. Ref. Book 161, Her Majesty's Stationery Office, Norwich, UK, 1984.
    15) Crowder JI & Sexton RR: Keratoconjunctivitis resulting from the sap of candelabra cactus and the pencil tree. Arch Ophthalmol 1964; 72:4766-484.
    16) Eberle MM, Erb C, & Flammer J: Dermatitis and conjunctivitis after contact with Euphorbia myrsinites (wolf's milk extract)-case report (German)(abstract). Klin Monatsbl Augenheilkd 1999; 215:203-204.
    17) Eke T, Al-Husainy S, & Raynor MK: The spectrum of ocular inflammation caused by Euphorbia plant sap. Arch Ophthalmol 2000; 118:13-16.
    18) Elliot CG, Colby TV, & Kelly TM: Charcoal lung. Bronchiolitis obliterans after aspiration of activated charcoal. Chest 1989; 96:672-674.
    19) Ellis CA, Brooks SF, & Brooks G: The efforts of phorbol esters with different biological activities on protein Kinase C. Phytoresearch 1987; 1:187-190.
    20) Eswarappa S, Chakraborty AR, Palatty BU, et al: Cleistanthus collinus poisoning: Case reports and review of the literature. J Toxicol - Clin Toxicol 2003; 41:369-372.
    21) Eswarappa S: Renal failure and neuromuscular weakness in Cleistanthus collinus poisoning. J Assoc Physicians India 2007; 55:85-86.
    22) FDA: Poison treatment drug product for over-the-counter human use; tentative final monograph. FDA: Fed Register 1985; 50:2244-2262.
    23) Flood WJ & Beardmore GL: Home treatment of basal cell carcinoma. Med J Aust 1976; 2:111-112.
    24) Forsyth AA: British Poisonous Plants, Bull 161, Ministry of Agr, Fisheries, and Food, London, UK, 1954.
    25) Freitas JC, Presgrave OA, & Fingola FF: Toxicological study of the molluscicidal latex of Euphorbia splendens: irritant action on skin and eye (abstract). Mem Inst Oswaldo Cruz 1991; 86 (Suppl 2):87-88.
    26) Frohne P & Pfander HJ: A Colour Atlas of Poisonous Plants, Wolfe Publishing Ltd, London, England, 1983.
    27) Furstenberger G & Hecker E: On the active principles of the Euphorbiaceae, XII. Highly unsaturated irritant diterpene esters from Euphorbia tirucalli originating from Madagascar. J Nat Prod 1986; 49:386-397.
    28) Golej J, Boigner H, Burda G, et al: Severe respiratory failure following charcoal application in a toddler. Resuscitation 2001; 49:315-318.
    29) Graff GR, Stark J, & Berkenbosch JW: Chronic lung disease after activated charcoal aspiration. Pediatrics 2002; 109:959-961.
    30) Gundidza M, Sorg B, & Hecker E: A skin irritant phorbol ester from Euphorbia cooperi NEBr (abstract). Cent Afr J Med 1992; 38:444-447.
    31) Gundidza M, Sorg B, & Hecker E: A skin irritant principle from Euphorbia matabelensis Pax (abstract). J Ethnopharmacol 1993; 39:209-212.
    32) Harris CR & Filandrinos D: Accidental administration of activated charcoal into the lung: aspiration by proxy. Ann Emerg Med 1993; 22:1470-1473.
    33) Hausen BM, Ketels-Harken H, & Schulz KH: Occupational allergy due to inhalation of pollen from Euphorbia fulgens Karw (author's transl)(German)(abstract). Dtsch Med Wochenschr 1976; 101:567-570.
    34) Hecker E: Aspects of cocarcinogenesis. In: Symington T & Carter R (ed), Scientific Foundations of Oncology, London, UK, 1976, pp 310-318.
    35) Hergenhahn M, Kusumoto S, & Hecker E: Diterpene esters from 'euphorbium' and their irritant and cocarcinogenic activity. Experientia 1974; 30:1438-1440.
    36) Hurst E: The Poisonous Plants of New South Wales, NSW Poison Plants Committee, Sydney, Australia, 1942.
    37) Itokawa H, Ichihara Y, & Watanabe K: An antitumor principle from Euphorbia lathyris. Planta Medica 1989; 55:271-272.
    38) Jaken S, Tashijan AH Jr, & Blumber PM: Characterization of phorbol ester receptors and their down-modulation in GH4C3 rat pituitary cells. Cancer Res 1981; 41:2175-2181.
    39) Khan AQ, Ahmend Z, & Kazml N-H: Further triterpenes from the stem bark of Euphorbia tirucalli. Planta Medica 1987; 53:577.
    40) Kikkawa U, Takai Y, & Tanaka Y: Protein kinase C as a possible receptor protein of tumour - promoting phorbol esters. J Biol Chem 1983; 258:11442-11445.
    41) Kinghorn AD & Evans FJ: A biological screen of selected species of the genus Euphorbia for skin irritant effects. Planta Medica 1975; 28:325-335.
    42) Kinghorn AD: Major skin irritant principles from Synadenium grantii. J Pharm Sci 1980; 69:1446-1447.
    43) Kinghorn AD: Toxic Plants, Columbia University Press, New York, NY, 1979.
    44) Kingsbury J: Poisonous Plants of the United States and Canada, Prentice Hall, Englewood Cliffs, NJ, 1964.
    45) Lampe KF & McCann MA: AMA Handbook of Poisonous and Injurious Plants, American Medical Association, Chicago, IL, 1985.
    46) Lawrence G: Taxonomy of Vascular Plants, Macmillian Press, New York, NY, 1951.
    47) Lin TJ, Su CC, Lan CK, et al: Acute poisonings with Breynia officinalis-an outbreak of hepatotoxicity. J Toxicol Clin Toxicol 2003; 41(5):591-594.
    48) Lisch K: The effect of the sap of Euphorbiaceae on the eye (German). Die Wirkung des Milchsaftes von Euphorbiazeen auf das Auge. Klin Monatsbl Augenheilkd 1980; 176:469-471.
    49) Lu Y & Yuan Y: Purification and properties of a ribosome inactivating protein, a toxin from the latex of Euphorbia marginata and its action on tumor cells. J Toxicol Toxin Rev 1990; 9:72.
    50) Malaisse WJ, Sener A, & Herchuelz A: Insulinotropic effect of the tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate in rat pancreatic islets. Cancer Res 1980; 40:3827-3831.
    51) Markby DP, Brooks G, & Evans AT: Checum (Poison Sap Tree) toxin, a potent activator of protein kinase C. Lancet 1989; 1:1320.
    52) Mitchell J & Rook A: Botanical Dermatology, Greengrass, Vancouver, BC, 1979.
    53) Mrvos R, Krenzelok EP, & Jacobsen TD: Toxidromes associated with the most common plant ingestions. Vet Human Toxicol 2001; 43:366-369.
    54) Naor Z & Catt KJ: Mechanism of action of gonadotropin-releasing hormone. Involvement of phospholipid turnover in luteinzing hormone release. J Biol Chem 1981; 256:2226-2229.
    55) Naradzay J & Barish RA: Approach to ophthalmologic emergencies. Med Clin North Am 2006; 90(2):305-328.
    56) None Listed: Position paper: cathartics. J Toxicol Clin Toxicol 2004; 42(3):243-253.
    57) Osborne R & Tashijan AH Jr: Tumor-promoting phorbol esters affect production of prolactin and growth hormone by rat pituitary cells. Endrocrinology 1981; 108:1164-1170.
    58) Pax F & Hoffman K: "Euphorbiaceae", in Engler A & Prantl K (ed): Die Naturlichen Pflanzenfamilien, 2nd ed, 19C, Engelmann, Leipzig, 1931.
    59) Peate WF: Work-related eye injuries and illnesses. Am Fam Physician 2007; 75(7):1017-1022.
    60) Pollack MM, Dunbar BS, & Holbrook PR: Aspiration of activated charcoal and gastric contents. Ann Emerg Med 1981; 10:528-529.
    61) Rau NR, Nagaraj MV, Prakash PS, et al: Fatal pulmonary aspiration of oral activated charcoal. Br Med J 1988; 297:918-919.
    62) Raymond WD: Native poisons and native medicines of Tanganyika. J Trop Med Hyg 1939; 42:295-303.
    63) Rook AJ: An unrecorded irritant plant, Synadenium grantii. Br J Dermatol 1965; 77:284.
    64) Scott IU & Karp CL: Euphorbia sap keratopathy: four cases and a possible pathogenic mechanism (abstract). Br J Ophthalmol 1996; 80:823-826.
    65) Shlamovitz GZ, Gupta M, & Diaz JA: A case of acute keratoconjunctivitis from exposure to latex of Euphorbia tirucalli (pencil cactus). J Emerg Med 2009; 36(3):239-241.
    66) Smith MA & Vale WW: Superfusion of rat anterior pituitary cells attached to Cytodex beads: validation of a technique. Endrocrinology 1980; 107:1425-1431.
    67) Sofat BK, Sood GC, & Chandel RD: Euphorbia royleana latex keratitis. Am J Ophthalmol 1972; 74:634-637.
    68) Sood GC, Sofat BK, & Chandel RD: Injury to the eye by the sap of Euphorbia royleana. Br J Ophthalmol 1971; 55:856-857.
    69) Sperry OE, Dollahite JW & Morrow J et al: Texas Range Plants Poisonous to Livestock. Texas Agr Expt Station Bull 796, 1955.
    70) Spoerke DG & Temple AR: Dermatitis after exposure to a garden plant (Euphorbia myrsinites). Am J Dis Child 1979; 133:28-29.
    71) Spoerke DG, Montanio CD, & Rumack BH: Pediatric exposure to the houseplant Synadenium grantii. Vet Hum Toxicol 1985; 28:283-284.
    72) Szallasi A, Sharkey NA, & Blumberg PM: Structure/activity analysis of reiniferatoxin analogs. Phytotherapy Res 1989; 3:253-254.
    73) Upadhyay RR, Ansarin M, & Azrintan MH: Tumor promoting constituent of Euphorbia serrata L. latex. Experienta 1976; 32:1196-1197.
    74) Vlachos P, Poulos L, & Koutselinis A: Euphorbia poisoning (case reports). IRCS Medical Science: Library Compendium 1978; 6:104.
    75) Watt JM & Breyer-Brandwijk MG: The Medicinal and Poisonous Plants of Southern Africa, 2nd ed, E. & S. Livingstone, Edinburgh, UK, 1962.
    76) Welsh TH Jr, Jones PBC, & Hsueh AJW: Phorbol ester inhibition of ovarian and testicular steroidogenesis in vitro. Cancer Res 1984; 44:885-892.
    77) Worobec SM, Hickey TA, & Kinghorn AD: Irritant contact dermatitis from an ornamental Euphorbia (abstract). Contact Dermatitis 1981; 7:19-22.
    78) Yeh E, Sharkey NA, & Blumberg PM: Influence of side chains on phorbol ester binding to protein kinase C. Phytother Res 1987; 1:135-139.